SAN FRANCISCO, July 2, 2013 /PRNewswire/ -- Invuity®, a leading developer of advanced visualization devices to optimize minimally invasive surgeries, announced that its Board of Directors unanimously elected Randall A. Lipps to the Board as an independent director. Mr. Lipps is Chairman, President and Chief Executive Officer of Omnicell, Inc. (NASDAQ: OMCL), a leading provider of systems that enable healthcare facilities to increase operational efficiency, enhance patient safety and allow clinicians to spend more time with patients.
"Invuity and I are like-minded in our commitment to helping physicians better serve patients, resulting in improved patient care and outcomes," said Mr. Lipps. "I am impressed with the broad benefits that Invuity's Eigr technology can provide across a health system, from improving existing surgeries to enabling new procedures in orthopedics to oncology and beyond. I look forward to working with the impressive team and helping the company continue its growth trajectory."
Mr. Lipps founded Omnicell in September 1992 and is currently Chairman of the Board of Directors as well as President and Chief Executive Officer. He has provided the leadership for Omnicell's business expansion and has led the company to a market cap of over $650 million. Since 2003, Omnicell has been recognized as one of the top 150 Silicon Valley companies, as measured by market capitalization, by the San Jose Mercury News.
"I'm honored to welcome Randy to Invuity's Board of Directors," said Philip Sawyer, CEO of Invuity. "Randy's deep knowledge of the U.S. hospital market is extremely relevant to our business, as is his understanding of the process of new technology adoption across hospital systems. We believe it will prove a very productive relationship and are really looking forward to working with him."
Eigr technology incorporates a proprietary optical waveguide technology with a complex geometry of integrated microstructures to shape illumination within the operative space. Eigr broadly projects thermally cool, brilliant light to uniformly illuminate deep surgical cavities, providing unsurpassed visualization while virtually eliminating shadows, glare and thermal hazards. Eigr waveguides are single use products.
Invuity develops advanced medical devices to dramatically improve access and visualization in minimally invasive and minimal access surgeries. The company's products incorporate its proprietary Eigr technology into sophisticated hand-held illumination devices and access systems for a variety of surgical specialties including spine, orthopedics, breast and thyroid oncology and plastic surgery. The company is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
Invuity and Eigr are trademarks or registered trademarks of Invuity, Inc.